Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a saline laxative used for bowel preparation before procedures and for the treatment of occasional constipation. It works by drawing water into the colon, which softens the stool and stimulates bowel movement.
## Primary Indications
* Bowel preparation for colonoscopy or other colonic procedures.
* Treatment of occasional constipation.
## Adult Dosing
**Bowel Preparation:**
* **Fleet Enema:** 1 single-use bottle (4.5 fl oz or approximately 133 mL) administered rectally as a single dose. Typically administered 1-5 hours prior to the procedure, or as directed by the healthcare provider.
* **Pre-packaged Enemas (e.g., containing 3 oz/90 mL of sodium phosphate 2.5% w/v and dibasic sodium phosphate 1% w/v):** 1 single-use bottle administered rectally as a single dose.
* **Oral Sodium Phosphate Solution (less common for enema indications, but may be used for bowel prep):** Dosing varies. For example, a common regimen involves taking two doses of 45 mL of oral sodium phosphate solution (11.25 grams sodium phosphate per 45 mL) the day before the procedure. *This is not for rectal administration.*
**Constipation:**
* **Fleet Enema:** 1 single-use bottle (4.5 fl oz or approximately 133 mL) administered rectally as a single dose. May be repeated in 24 hours if necessary.
## Pediatric Dosing
Dosing for pediatric patients is not well-established and should be determined by a healthcare provider, often based on weight and clinical judgment.
* **Children 12 years and older:** Same as adult dose.
* **Children under 12 years:** Use with caution. Specific dosing depends on the product and healthcare provider guidance. Some sources suggest lower doses for younger children (e.g., 2.5 fl oz for children 2-11 years), but this should be confirmed with product labeling and clinician advice.
## Dose Adjustments
No dose adjustments are typically required for hepatic or renal impairment when used as an enema, but caution is advised due to the risk of electrolyte disturbances.
## Contraindications
* Congestive heart failure.
* Renal impairment or renal insufficiency.
* Congenital or acquired megacolon.
* Intestinal obstruction or perforation.
* Abnormalities of the gastrointestinal tract (e.g., stenosis).
* Anuria.
* Children under 2 years of age (due to risk of hypernatremia, hyperphosphatemia, hypocalcemia, and dehydration).
* Patients with ileostomy or colostomy.
* Concurrent use of other sodium-raising agents.
* Patients on sodium-restricted diets.
## Adverse Effects
* **Electrolyte Imbalance:** Hypernatremia, hyperphosphatemia, hypocalcemia, hypokalemia. This is the most significant concern, especially in patients with renal impairment, children, or with overuse. Symptoms can include nausea, vomiting, abdominal cramping, dehydration, dizziness, and in severe cases, seizures, cardiac arrhythmias, and renal failure.
* **Gastrointestinal:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation or pain, diarrhea.
* **Dehydration.**
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalance.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **Calcium channel blockers:** Increased risk of hyperkalemia.
* **Other laxatives:** Increased risk of dehydration and electrolyte imbalance.
* **Drugs affecting electrolyte balance:** Concurrent use may exacerbate electrolyte disturbances.
## Monitoring
* **Renal function:** Monitor serum creatinine, BUN, electrolytes (sodium, potassium, phosphate, calcium) especially in patients with risk factors for renal impairment or electrolyte disturbances, or with repeated use.
* **Hydration status:** Assess for signs of dehydration.
* **Bowel movements:** Monitor frequency and consistency.
## Clinical Pearls
* Sodium phosphate enemas are potent osmotic laxatives and should be used with caution and as directed.
* Overuse or misuse can lead to severe electrolyte abnormalities, particularly hyperphosphatemia and hypocalcemia, which can be life-threatening.
* Ensure adequate fluid intake before and after administration, especially in children and the elderly.
* Avoid use in patients with contraindications due to the high risk of serious adverse events.
* If constipation persists after use, further evaluation is warranted.
* For bowel preparation, follow specific institutional protocols or healthcare provider instructions precisely.
***
*Please consult the most current prescribing information and institutional protocols for definitive guidance. This information is intended for healthcare professionals and does not replace clinical judgment.*
